secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001437749-24-022919
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OPKO Health issues $250M senior secured notes due 2044, secured by NGENLA profit share payments from Pfizer
--------------------------------------------------------------------------------

- Notes bear interest at 3-month SOFR + 7.5% (floor 4%); interest-only for first 4 years.
- No principal payments required before July 2028; principal repaid from NGENLA profit share payments.
- Proceeds provide non-dilutive capital for R&D, including multispecific antibody programs, and potential share/convertible note repurchases.
- Exit fee of 3% on repayment; make-whole provision up to 200% of principal if prepaid after year 5.
- OPKO retains full benefit of up to $100M in remaining milestone payments from Pfizer for NGENLA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/0001437749-24-022919-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/opk20240717_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022919

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer